--2025/Q1-- / 6.589M--
--2024/Q4-- / 9.479M--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2022/Q40.000 / 0.000--
MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
NVIDIA
NVDA
Tesla
TSLA
US Stock MarketDetailed Quotes
MREO Mereo BioPharma
- 2.8600
- -0.0400-1.38%
Close Jan 17 16:00 ET
- 2.8700
- +0.0100+0.35%
Post 19:58 ET
443.72MMarket Cap-9.53P/E (TTM)
2.9300High2.8000Low1.17MVolume2.8900Open2.9000Pre Close3.32MTurnover1.16%Turnover RatioLossP/E (Static)155.15MShares5.020052wk High6.11P/B287.15MFloat Cap2.525052wk Low--Dividend TTM100.40MShs Float8.4800Historical High--Div YieldTTM4.48%Amplitude0.3010Historical Low2.8420Avg Price1Lot Size
Mereo BioPharma Key Stats
Mereo BioPharma Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: GBP
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Mereo BioPharma Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data